Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 6609 (116th)

Immediate COVID Testing Procurement Act.

referredUnited States· United States Congress· EN

Introduced

23 April 2020

Last action

23 April 2020 · Introduced

Status

Referred to the House Committee on Financial Services.

Sponsors

Rep. Panetta, Jimmy [D-CA-19], Rep. Brown, Anthony G. [D-MD-4], Rep. Chu, Judy [D-CA-28], Rep. Cisneros, Gilbert Ray [D-CA-31], Rep. DeFazio, Peter A. [D-OR-4], Rep. Espaillat, Adriano [D-NY-13], Rep. Gabbard, Tulsi [D-HI-2], Rep. Grijalva, Raúl M. [D-AZ-7], Rep. Hastings, Alcee L. [D-FL-20], Rep. Huffman, Jared [D-CA-2], Rep. Kilmer, Derek [D-WA-6], Rep. Loebsack, David [D-IA-2], Rep. Malinowski, Tom [D-NJ-7], Rep. Maloney, Sean Patrick [D-NY-18], Rep. Meng, Grace [D-NY-6], Rep. Nadler, Jerrold [D-NY-12], Rep. Napolitano, Grace F. [D-CA-32], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Payne, Donald M., Jr. [D-NJ-10], Rep. Phillips, Dean [D-MN-3], Rep. Rice, Kathleen M. [D-NY-4], Rep. Ruppersberger, C. A. Dutch [D-MD-2], Rep. Rush, Bobby L. [D-IL-1], Rep. Schneider, Bradley Scott [D-IL-10], Rep. Sewell, Terri A. [D-AL-7], Rep. Sires, Albio [D-NJ-13], Rep. Spanberger, Abigail Davis [D-VA-7], Rep. Suozzi, Thomas R. [D-NY-3], Rep. Vela, Filemon [D-TX-34], Rep. Richmond, Cedric L. [D-LA-2], Rep. McGovern, James P. [D-MA-2], Rep. Cox, TJ [D-CA-21], Rep. Beyer, Donald S. [D-VA-8], Rep. Luria, Elaine G. [D-VA-2], Rep. Pocan, Mark [D-WI-2], Rep. Demings, Val Butler [D-FL-10]

Subjects

Defence

Source updated

3 January 2025

Defence

Official sourceDownload fileView documentsShare

Summary

Immediate COVID Testing Procurement Act This bill requires the President, within 24 hours of this bill's enactment, to issue purchase orders for a program of the highest national urgency (commonly known as a DX purchase order) to procure under the Defense Production Act of 1950 (DPA) supplies to conduct COVID-19 (i.e., coronavirus disease 2019) medical testing nationwide. The supplies must have received prior approval from the Centers for Disease Control and Prevention or have received emergency use authorization from the Food and Drug Administration for the detection of COVID-19. The bill waives certain DPA requirements relating to industrial resource and critical technology shortfalls and notification to Congress.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 23 April 2020

    Introduced

    Referred to the House Committee on Financial Services.

    Source: IntroReferral

  2. 23 April 2020

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 23 April 2020

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 23 April 2020

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 23 April 2020

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 23 April 2020

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.